Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index
Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid
Irisin in patients with nonalcoholic fatty liver disease
Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
Clustering of Long-term Trends in Metabolic Syndrome Variables from Childhood to Adulthood in Blacks and Whites: The Bogalusa Heart Study
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Lower circulating irisin is associated with type 2 diabetes mellitus
Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo
Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance
Prevalence of a Metabolic Syndrome Phenotype in Adolescents
Variations in pattern of pubertal changes in girls.
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway
Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults
Circulating Irisin Concentrations Are Associated with a Favourable Lipid Profile in the General Population
Irisin and Its Relation to Insulin Resistance and Puberty in Obese Children: A Longitudinal Analysis
Pathobiological Determinants of Atherosclerosis in Youth Risk Scores Are Associated With Early and Advanced Atherosclerosis
Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes
Childhood Body Composition in Relation to Body Mass Index
Serum irisin levels in new-onset type 2 diabetes
Reduced Expression of FOXC2 and Brown Adipogenic Genes in Human Subjects with Insulin Resistance
Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study.
Irisin in Response to Exercise in Humans With and Without Metabolic Syndrome
2007 Korean National Growth Charts: review of developmental process and an outlook